— Know what they know.
Not Investment Advice

OMIC NASDAQ

Singular Genomics Systems, Inc.
1W: +0.3% 1M: +0.6% 3M: -8.6% 1Y: +26.1% 3Y: -91.4%
$20.01
Last traded 2025-02-21 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies · $50.8M mcap · 2M float · 0.729% daily turnover

Balance Sheet Trends

Total Assets
$265M -19.1% ▼
4Y CAGR: +53.2%
Total Liabilities
$86M +27.8% ▲
4Y CAGR: +4.4%
Shareholders Equity
$179M -31.2% ▼
Cash & Investments
$174M -28.9% ▼
4Y CAGR: +39.3%
Total Debt
$75M +27.9% ▲
4Y CAGR: +136.7%
Net Debt
$59M +482.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$6M$12M$201M$74M$16M
Short-Term Investments$41M$15M$138M$170M$158M
Cash & ST Investments$46M$27M$339M$245M$174M
Net Receivables$0$17K$1M$2M$2M
Inventory$0-$17K$3M$18M$14M
Other Current Assets$261K$0$761K$620K$1M
Total Current Assets$46M$28M$348M$268M$192M
Property, Plant & Equip.$2M$2M$6M$57M$71M
Goodwill & Intangibles$0$0$0-$15M$0
Long-Term Investments$23K$482K$687K$2M$600K
Other Non-Current Assets$81K$81K$1M$3M$1M
Total Non-Current Assets$2M$3M$8M$60M$73M
Total Assets$48M$31M$356M$328M$265M
— Liabilities —
Accounts Payable$561K$427K$2M$3M$3M
Short-Term Debt$0$926K$0$6M$8M
Deferred Revenue$0$2M$0$5M-$3M
Other Current Liabilities$500K$1M$4M-$3M-$678K
Total Current Liabilities$1M$4M$7M$14M$18M
Long-Term Debt$2M$8M$10M$10M$9M
Other Non-Current Liab.$69M$70M$3M$1M$650K
Total Non-Current Liabilities$72M$78M$13M$54M$68M
Total Liabilities$73M$82M$19M$68M$86M
— Equity —
Common Stock$1K$1K$7K$7K$7K
Retained Earnings-$25M-$53M-$152M-$243M-$338M
Accumulated OCI$14K$17K-$138K-$837K$155K
Total Stockholders Equity-$25M-$52M$336M$260M$179M
Total Liabilities & Equity$48M$31M$356M$328M$265M
— Key Metrics —
Total Debt$2M$9M$10M$59M$75M
Net Debt-$3M-$2M-$191M-$15M$59M
Total Investments$41M$16M$139M$172M$158M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms